552 related articles for article (PubMed ID: 23928305)
1. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
[TBL] [Abstract][Full Text] [Related]
2. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.
Lin T; Ponn A; Hu X; Law BK; Lu J
Oncogene; 2010 Sep; 29(35):4896-904. PubMed ID: 20562920
[TBL] [Abstract][Full Text] [Related]
3. SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors.
Zhang J; Bonasio R; Strino F; Kluger Y; Holloway JK; Modzelewski AJ; Cohen PE; Reinberg D
Genes Dev; 2013 Apr; 27(7):749-66. PubMed ID: 23592795
[TBL] [Abstract][Full Text] [Related]
4. HMG20A is required for SNAI1-mediated epithelial to mesenchymal transition.
Rivero S; Ceballos-Chávez M; Bhattacharya SS; Reyes JC
Oncogene; 2015 Oct; 34(41):5264-76. PubMed ID: 25639869
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.
Ambrosio S; Saccà CD; Majello B
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):905-910. PubMed ID: 28720390
[TBL] [Abstract][Full Text] [Related]
6. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
[TBL] [Abstract][Full Text] [Related]
7. MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition.
Luo H; Shenoy AK; Li X; Jin Y; Jin L; Cai Q; Tang M; Liu Y; Chen H; Reisman D; Wu L; Seto E; Qiu Y; Dou Y; Casero RA; Lu J
Cell Rep; 2016 Jun; 15(12):2665-78. PubMed ID: 27292636
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program.
Lin S; Shen H; Li JL; Tang S; Gu Y; Chen Z; Hu C; Rice JC; Lu J; Wu L
J Biol Chem; 2013 Mar; 288(9):6238-47. PubMed ID: 23349461
[TBL] [Abstract][Full Text] [Related]
9. TdIF1-LSD1 Axis Regulates Epithelial-Mesenchymal Transition and Metastasis via Histone Demethylation of E-Cadherin Promoter in Lung Cancer.
Liu Q; Xiong J; Xu D; Hao N; Zhang Y; Sang Y; Wang Z; Zheng X; Min J; Diao H; Raphael J; Maleki Vareki S; Koropatnick J; Min W
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008676
[TBL] [Abstract][Full Text] [Related]
10. GR and LSD1/KDM1A-Targeted Gene Activation Requires Selective H3K4me2 Demethylation at Enhancers.
Clark EA; Wu F; Chen Y; Kang P; Kaiser UB; Fang R; Shi YG
Cell Rep; 2019 Jun; 27(12):3522-3532.e3. PubMed ID: 31216473
[TBL] [Abstract][Full Text] [Related]
11. UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1.
Choi HJ; Park JH; Park M; Won HY; Joo HS; Lee CH; Lee JY; Kong G
EMBO Rep; 2015 Oct; 16(10):1288-98. PubMed ID: 26303947
[TBL] [Abstract][Full Text] [Related]
12. HOTAIR lncRNA promotes epithelial-mesenchymal transition by redistributing LSD1 at regulatory chromatin regions.
Jarroux J; Foretek D; Bertrand C; Gabriel M; Szachnowski U; Saci Z; Guo S; Londoño-Vallejo A; Pinskaya M; Morillon A
EMBO Rep; 2021 Jul; 22(7):e50193. PubMed ID: 33960111
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
[TBL] [Abstract][Full Text] [Related]
14. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
15. Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in
Miller SA; Policastro RA; Savant SS; Sriramkumar S; Ding N; Lu X; Mohammad HP; Cao S; Kalin JH; Cole PA; Zentner GE; O'Hagan HM
Mol Cancer Res; 2020 Feb; 18(2):264-277. PubMed ID: 31704733
[TBL] [Abstract][Full Text] [Related]
16. Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate.
Kim SA; Zhu J; Yennawar N; Eek P; Tan S
Mol Cell; 2020 Jun; 78(5):903-914.e4. PubMed ID: 32396821
[TBL] [Abstract][Full Text] [Related]
17. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
[TBL] [Abstract][Full Text] [Related]
18. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.
Lan F; Collins RE; De Cegli R; Alpatov R; Horton JR; Shi X; Gozani O; Cheng X; Shi Y
Nature; 2007 Aug; 448(7154):718-22. PubMed ID: 17687328
[TBL] [Abstract][Full Text] [Related]
19. Molecular mimicry and ligand recognition in binding and catalysis by the histone demethylase LSD1-CoREST complex.
Baron R; Binda C; Tortorici M; McCammon JA; Mattevi A
Structure; 2011 Feb; 19(2):212-20. PubMed ID: 21300290
[TBL] [Abstract][Full Text] [Related]
20. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
